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Introduction {#sec1}
============

Bacterial toxins of the cholesterol-dependent cytolsysin (CDC) superfamily form pores in lipid bilayers through the oligomerization of their membrane attack complex/perforin fold (MACPF) domain. CDCs are produced by over five different genera of Gram-positive bacteria, resulting in a wide range of animal and human diseases ([@bib45]). Intermedilysin (ILY) is a CDC secreted by *Streptococcus intermedius* that causes brain and liver abscesses in its host ([@bib34]) and is thought to be the major virulence factor for the bacterium ([@bib34]). Cholesterol is essential for ILY cytolytic activity, and crystal structures of ILY and other CDCs show strong structural homology ([@bib5]; [@bib37]; [@bib39]; [@bib40]; [@bib48]). Most CDCs bind to cholesterol-rich membranes via a cholesterol recognition motif (CRM) and neighboring undecapeptide. This binding triggers the oligomerization and allosteric regulation of the transition to the pore state ([@bib7]). ILY, on the other hand, has evolved to recruit the human complement regulator CD59 as a receptor providing the basis for its species specificity ([@bib13]). It is CD59-binding that promotes both oligomerization of ILY monomers on the cell surface ([@bib24]) and the structural rearrangements required for pore formation ([@bib7]). In contrast, the interaction of cholesterol with the CRM and undecapeptide is required for the maintenance of the ILY prepore at the membrane as CD59 is released ([@bib24]). Mutational analysis of ILY has determined residues involved in both lipid and receptor binding ([@bib46]) as well as those crucial for mediating structural transitions ([@bib7]; [@bib18]; [@bib24]; [@bib42], [@bib43]). Our structure of the ILY-CD59 complex now provides a framework with which to integrate these biochemical and biophysical data.

CD59 is the only membrane-bound inhibitor of the complement terminal pathway ([@bib32]). This small (77 amino acid) GPI-anchored cell-surface receptor binds complement components C8 and C9 ([@bib36]) and directly inhibits the formation of the membrane attack complex (MAC), an immune pore that kills microbes by the disruption of lipid bilayers. CD59 is expressed on a variety of cell types, including leukocytes, epithelial, and endothelial cells ([@bib33]) and plays an important role in preventing complement-mediated tissue damage in hosts. CD59 has been implicated in a number of human diseases, including tumor cell evasion during monoclonal antibody treatments ([@bib10]; [@bib14]) and paroxysmal nocturnal hemoglobinuria ([@bib17]). Structural studies of soluble CD59 ([@bib11]; [@bib22]; [@bib26]) and direct binding assays of CD59 with complement components ([@bib20]) have provided some insight into the role of this receptor in regulating MAC assembly. However, a lack of structural information characterizing CD59 with its binding partners has limited our ability to control complement susceptibility.

Here, we report the crystal structure of CD59 bound to ILY, a bacterial toxin that directly competes for MAC binding. We define two interfaces on CD59 that coordinate ILY monomers and validate this interaction through the development of a liposome-based model system. Cholesterol-containing liposomes decorated with cytotopic CD59 capture ILY monomers and support pore formation in a fluorescence-based assay. We also find that an ILY-derived peptide based on our structure disrupts the interface and competes for pore formation. In addition, cryo-electron microscopy (cryo-EM) images of the crystallized ILY mutant bound to CD59-decorated liposomes suggest that the linear arrays observed in our crystal could also occur in the context of a membrane. Altogether, our structural and functional data provide mechanistic insight into how CD59 engages ILY for the formation of a pore in lipid bilayers, providing a basis for the development of new antibiotics as well as potential therapeutics that target CD59.

Results {#sec2}
=======

Crystal Structure of the ILY-CD59 Complex Reveals Two Interfaces {#sec2.1}
----------------------------------------------------------------

An early prepore intermediate comprising the initial attachment of ILY to CD59 was captured with a disulfide-locked ILY mutant (ILY^EPP^) and a CD59 construct lacking the GPI anchor. Both proteins were expressed and purified independently. The complex was assembled in vitro, subjected to further purification, and crystallized. The crystals diffracted to a resolution of 3.5 Å, and the structure was solved by molecular replacement. The final model, consisting of all four domains of ILY and the ectodomain of CD59, was refined to a final R~work~/R~free~ of 21.2%/26.6% and displayed good geometry ([Figures 1](#fig1){ref-type="fig"} and [S1](#figs1){ref-type="fig"}A; [Table 1](#tbl1){ref-type="table"}).

As described previously, ILY is comprised of four structural domains, the first three of which are formed from discontinuous stretches of sequence. Domain 1 (D1) (residues 56--76, 117--201, 258--299, and 379--399) forms a cap at the top of the molecule and is the least well-ordered region of our crystal ([Figure S1](#figs1){ref-type="fig"}B). Domain 2 (D2) (residues 77--116 and 400--417) consists of three kinked β strands that span 50 Å and bridge domains 1 and 4. Domain 3 (D3) (residues 202--257 and 300--378) packs against D2 and contains the helical bundles that are predicted to refold into transmembrane β-hairpins. This domain, along with D1, makes up the MACPF domain and also contains the site of the engineered disulfide bond (C346-C361) that prevents the structural rearrangements required for full pore formation. Finally, domain 4 (D4) (residues 418--528) is a discrete β sandwich structure extending from the end of D2. CD59 is a compact, heavily disulfide-bonded structure with a central β sheet bookended by a short α helix and a two-strand β hairpin.

The asymmetric unit of the crystal contains two copies of the ILY-CD59 complex, which overlay with an RMSD of 1.0 Å over 530 residues. CD59 predominantly interacts with D4 of ILY ([Figure 1](#fig1){ref-type="fig"}A), which is in agreement with previous studies ([@bib35]; [@bib37]). Strikingly, there are two major ILY-CD59 interfaces within the crystal: one within the asymmetric unit and one between neighboring unit cells ([Figure 1](#fig1){ref-type="fig"}B).

The primary ILY-CD59 binding site (665 Å^2^ buried surface area) is composed of a side-to-side contact between the β hairpin extension of ILY D4 (the β2-β3 loop) and the core β sheet of CD59 ([Figure 1](#fig1){ref-type="fig"}C), effectively creating an extension of the CD59 sheet. The interface is further stabilized by the stacking of hydrophobic side-chains (ILY:Y436, ILY:I450, CD59:F47, CD59:Y61, and CD59:F42) as well as an extensive network of hydrogen bonds (both sidechain-sidechain and sidechain-backbone) and salt bridges (ILY:R480, CD59:E58; ILY:448, CD59:K65; ILY:D445, and CD59:K66). This interface is supported by two independent mutagenesis studies ([@bib21]; [@bib46]). Specifically, ILY double (Y434A/Y436A) and triple (S499N/K500R/N501T) mutants located within our primary CD59 interface ([Figure 1](#fig1){ref-type="fig"}C) dramatically inhibited pore formation and decreased the affinity of ILY for CD59. In addition, double- and single-point mutations in CD59 have implicated aromatic residues that map to this interface (F42, F47, and Y62) as being involved in ILY binding ([@bib46]).

The secondary binding site is formed by the same region of ILY (the β2-β3 loop in D4) interacting with CD59 from a neighboring unit cell. This interface buries 500 Å^2^ and is stabilized by a series of hydrogen bonds and three salt bridges (ILY:D443, CD59:R55; ILY:D445, CD59:K38; ILY:E93, and CD59:K41). The second interface is again validated by previous mutagenesis studies of both ILY and CD59 ([@bib46]). In particular, a double mutation in ILY (R451A/S452A) that reduces CD59-binding and hemolysis maps to this region ([Figure 1](#fig1){ref-type="fig"}D). CD59 mutations D22 and F23, also located in this interface ([Figure 1](#fig1){ref-type="fig"}D), play a role in ILY binding and function. Therefore, CD59 displays two distinct binding sites for ILY that can be simultaneously occupied. This suggests that, in addition to localizing ILY to the membrane surface, CD59 helps nucleate an early prepore complex by bridging neighboring ILY molecules, thereby creating the linear array observed in our crystals.

Probing the ILY-CD59 Interfaces within the Context of a Cholesterol-Containing Membrane {#sec2.2}
---------------------------------------------------------------------------------------

To address the functional significance of the ILY-CD59 interfaces observed in our crystal structure, we developed a simple model membrane system to probe ILY pore formation in a fluorescence-based assay ([@bib23]). Calcein-containing liposomes were decorated with soluble CD59 and modified to possess a myristoylated lysine-rich "cytotopic" peptide ([@bib12]). Lipid attachment of cytotopic CD59 was confirmed by the colocalization of protein in lipid-containing fractions across a Ficoll gradient ([Figure 2](#fig2){ref-type="fig"}A). The fluorescence intensity of calcein released from liposomes upon lysis was used to determine the rate of pore formation. Exposure of wild-type ILY (ILY^WT^) with cholesterol-containing CD59-decorated liposomes resulted in functional transmembrane pores ([Figure 2](#fig2){ref-type="fig"}B), whereas undecorated liposomes did not support lysis ([Figure 2](#fig2){ref-type="fig"}B). Furthermore, incubation of liposomes with cytoptic CD59 alone did not leak calcein ([Figure 2](#fig2){ref-type="fig"}B). To confirm binding of the ILY β hairpin extension to CD59, a peptide comprised of ILY residues 438--452 was synthesized with bridging N- and C-terminal cysteines. CD59-containing liposomes were incubated with increasing concentrations of peptide and subjected to ILY lysis. The peptide successfully competed for CD59 binding and inhibited ILY pore formation with an IC~50~ of approximately 25 μM ([Figures 2](#fig2){ref-type="fig"}C and [S2](#figs2){ref-type="fig"}).

To understand how CD59 coordinates ILY monomers to form the pore, we characterized the complex in a lipid environment using electron microscopy. Because negatively stained specimens could lead to distortions of liposome curvature and possible liposome collapse, we used cryo-EM to visualize membrane-bound complexes. Examination of cryo-EM fields of ILY^WT^-CD59-liposome complexes revealed a population of liposomes with multiple instances of embedded circular pores ([Figure 3](#fig3){ref-type="fig"}A). Density is clearly visible for the ILY^WT^ protein rings with obvious disruption to the lipid bilayer. The diameter of the ILY^WT^ pore is approximately 300 Å, consistent with the dimensions previously reported for other CDC and perforin pores ([@bib25]; [@bib44]). To test the ability of the crystallized ILY mutant (ILY^EPP^) to form linear arrays in the context of a membrane, we examined two-dimensional cryo-EM images of the mutant form bound to CD59-decorated liposomes ([Figure 3](#fig3){ref-type="fig"}B). As expected, no perforation of the lipid bilayer was observed with this prepore intermediate. Protein density on the periphery of liposomes appears to be organized in linear clusters; however, due to the fragility of the system, we were unable to collect in-plane images to confirm this. Reversible linear arrays of a prepore-trapped mutant form of perfringolysin have demonstrated that CDCs undergo transient, yet specific, intermolecular interactions that precede ring closure ([@bib18]). These data suggest that the linear organization of ILY-CD59 complexes observed in our crystal structure is relevant for understanding how ILY engages with CD59 in the context of a membrane.

Model for the ILY Early Prepore {#sec2.3}
-------------------------------

Previously reported cryo-EM reconstructions of the pneumolysin prepore and pore structures have provided a model for how CDCs oligomerize on membranes ([@bib44]). Preserving the two ILY-CD59 interfaces observed in our crystal structure, we used this as a starting point to turn the linear array of our lattice into a model for the ILY early prepore state (see [Experimental Procedures](#sec4){ref-type="sec"} for details). This arrangement places CD59 at the periphery of the ring ([Figure 4](#fig4){ref-type="fig"}), and we find that the presence of CD59 would not obstruct ILY oligomerization, in concordance with data showing that CD59 remains bound during prepore assembly ([@bib24]). These data, along with the high concentration of CD59 on the cell surface ([@bib3]), have led us to include CD59 in our model of an ILY prepore oligomeric ring. The subsequent release of CD59 during the pore transition, observed previously by biophysical studies ([@bib24]), could be due in part to conformational changes that are incompatible with maintaining CD59 in the complex. In our model, the C-terminal residue of CD59 preceding the GPI anchor is positioned approximately 15 Å from the plane of the membrane ([Figure 4](#fig4){ref-type="fig"}). This observation is consistent with distances measured for other GPI-anchored proteins ([@bib29]) and with a model previously proposed for CD59 glycosylation ([@bib41]). Therefore, our structural and functional data together suggest that the role of CD59 in ILY pore formation is to orient the ILY CRM and undecapeptide proximal to cholesterol-containing lipid bilayers and to propagate ILY monomer-monomer interactions through two binding interfaces.

Discussion {#sec3}
==========

Structural studies of CDCs ([@bib5]; [@bib37]; [@bib39]; [@bib40]; [@bib48]) and components of the complement MAC ([@bib2]; [@bib15]; [@bib16]; [@bib30]) reveal that the fundamental pore-forming mechanism of these MACPF-containing proteins are similar. Both involve the conversion of water-soluble proteins to transmembrane oligomeric pores. However, within this conserved mechanism, one of the most important differences remains in its regulation. For many CDCs, membrane binding by the CRM and undecapeptide initiates structural transitions ([@bib7]), which are propagated between membrane-bound monomers ([@bib18]). Circularization of the CDC oligomeric ring then triggers a dramatic conformational change in which helical segments from D3 convert to amphipathic hairpins and arrange into a transmembrane β-barrel pore ([@bib44]). For a subclass of CDCs, of which ILY is an archetypal member, control of regulating prepore transitions is transferred from the undecapeptide to CD59 binding ([@bib7]).

Our structural and functional analysis of the ILY-CD59 complex supports a model for these pores in which membrane-anchored CD59 recruits soluble ILY monomers to the plasma membrane of human cells, orienting the CRM and undecapeptide for insertion into cholesterol-containing lipid bilayers. Through two distinct ILY-binding interfaces on opposite sides of the molecule, CD59 brings together ILY monomers in order to facilitate intermolecular interactions that drive the formation of an oligomeric prepore ring. Relatively small alterations to the packing of our crystal lattice produces a 31-fold symmetric model for this early prepore state that agrees with a pneumolysin prepore model ([@bib44]). Even smaller manipulations of our lattice produce alternate models for ILY pores in line with the proposed stoichiometries observed for other CDCs by different biophysical techniques (31- to 44-fold) ([@bib6]; [@bib44]).

Monomer-monomer interactions of CDCs have been shown to propagate early structural transitions required for pore formation ([@bib18]). Specifically, the positioning of neighboring molecules has been suggested to allow the intermolecular pairing of β1 from D3 of one molecule with β4 from the equivalent domain of the next. Analysis of the impact of applying curvature to our linear array shows that these contacts are indeed partially formed in our model ([Movie S1](#mmc1){ref-type="supplementary-material"}). In order to complete the zippering of the sheet-formation, β5 would need to swing out of the way. This transition is prevented in our crystal by the engineered disulfide bond in ILY^EPP^ locking β5 to β4, thus trapping the earliest prepore state.

Although ILY and MAC components (C8 and C9) all bind CD59, the result of this interaction has profoundly different outcomes on pore formation. Although CD59 promotes the oligomerization of ILY monomers ([@bib24]), the receptor inhibits MAC formation by preventing membrane perforation and incorporation of multiple C9 molecules ([@bib9]; [@bib32]; [@bib38]). ILY directly competes for the MAC binding site on CD59 ([@bib24]; [@bib46]), and a mutational analysis has confirmed that the ILY and MAC binding sites on the surface of CD59 overlap, at least in part ([@bib4]; [@bib19]; [@bib46]). CD59-binding MAC components lack the structural equivalent of ILY D4, therefore precluding further insight into how specific residues of C8 and C9 interact with the complement receptor. However, it is possible that CD59 engages the transmembrane segments of complement components after their transition to β hairpins but prior to membrane insertion, similar to the interaction of CD59 with the β hairpin extension of ILY D4. It is interesting to note that the residues on CD59 involved in MAC binding map to the same two opposing faces observed in our ILY interaction. CD59 inhibits MAC assembly most efficiently when incorporated prior to the addition of C9 ([@bib28]). Subsequently, it appears to lock a single C9 molecule into the complex in a conformation that prevents membrane perforation and further C9 recruitment ([@bib28]; [@bib32]). These observations, along with the ILY-CD59 crystal structure, suggest a mechanism for MAC inhibition whereby CD59 intercalates between C8 and C9 in an analogous manner to the ILY nucleation, locking the MAC in a nonfunctional state.

In summary, our findings provide mechanistic insights into how ILY pores form, revealing a dual role of CD59 in facilitating the assembly of the oligomeric prepore. Our structural and functional data have defined two CD59-ILY interaction interfaces, providing a framework for the development of new antibiotics and CD59-targeted therapeutics that could improve human health.

Experimental Procedures {#sec4}
=======================

Expression and Purification of the ILY-CD59 Complex {#sec4.1}
---------------------------------------------------

Recombinant soluble human CD59 with an additional C-terminal cysteine residue was expressed in *E.coli*, refolded, and purified from solubilized inclusion bodies as described previously ([@bib26]). Purified CD59 (approximately 0.5 mM in phosphate-buffered saline \[pH7.3\] PBS) was treated for 16 hr at ambient temperature with two molar equivalents of tris-2-carboxyethyl phosphine (TCEP, Sigma-Aldrich) for the generation of a free thiol at the carboxyl terminal cysteine of the protein. This was incubated for 2 hr at ambient temperature with a 3-fold molar excess of the cytotopic modification reagent bis-myristoyl lysyl SSKKSPSKKDDKKPGD (S-2-thiopyridyl)-cysteine acid (APT3146, Cambridge Research Biochemicals) for the generation of cytotopic CD59 ([@bib17]). Cytotopic CD59 was further purified by hydrophobic interaction chromatography and ammonium sulfate precipitation. The main protein peak fractions were pooled, buffer exchanged into PBS, and stored at --70°C until use.

An *ily* gene lacking cysteine residues (ILY^WT^) and a disulfide-locked *ily* mutant containing the substitutions T346C and I361C (ILY^EPP^) were cloned into a pTrcHisA vector and were generous gifts from R. Tweten. This early prepore form of ILY was characterized previously ([@bib24]) and shown to be converted to functional pores by the addition of reducing agent. Recombinant ILY proteins were expressed in Rosetta-2 cells (Novagen). Cells were grown to an optical density of 0.6 at 37°C and induced with 0.5 mM IPTG for 4 hr. Cultures were pelleted and lysed in a buffer containing 1% Triton, 200 mM NaCl, 20 mM Tris (pH 6.8), Protease Inhibitor Mixture (Sigma-Aldrich, 50 μl per gram of cell pellet), 100 μg of DNase I, and 100 μg of RNase A (Sigma-Aldrich). Cleared lysates were loaded onto cobalt-chelated TALON beads (Clontech) and eluted with 500 mM imidazole. ILY was further purified by size exclusion chromatography in 150 mM NaCl and 20 mM Tris (pH 6.8). ILY and CD59 were incubated at room temperature in a 1:2 molar ratio, and the complex was separated on a Superdex 200 HR 10/30 column (Pharmacia Biotech).

Crystallization and Data Collection {#sec4.2}
-----------------------------------

Crystals were grown by vapor diffusion at room temperature in 96-well plates with 0.4 μl droplets at 21°C. Equal volumes of preformed ILY^EPP^-CD59 complex (9.9 mg/ml in 150 mm NaCl, and 20 mM Tris \[pH 6.8\]) and precipitant (20% PEG6000, 0.1 M HEPES \[pH 7\], and 0.2 M LiCl) were mixed. Crystals were cryo-protected with reservoir solution plus 20% glycerol before cryo-cooling in liquid nitrogen. Data were collected at Diamond Light Source (Harwell Science and Innovation) at beamline I04.

Structure Determination and Refinement {#sec4.3}
--------------------------------------

Diffraction data were processed with xia2 ([@bib47]) in 3diir mode and initially assigned as P2~1~ with a single copy of the complex per asymmetric unit (indexing initially suggested C222 ~(1)~, but this failed upon scaling, see the twinning discussion below). The structure of the ILY-CD59 complex was solved by molecular replacement with the use of Phaser ([@bib31]). A solution was reached with the use of the known structures of ILY (PDB [1S3R](pdb:1S3R){#intref0010}) ([@bib37]) and CD59 (PDB [2UWR](pdb:2UWR){#intref0015}) ([@bib26]), with the ILY split into two search models encompassing D1--D3 and D4. Analysis of the data with Xtriage ([@bib1]) suggested that the data were twinned, and the structure was refined with Phenix ([@bib1]) with the pseudomerohedral twinning operator (h,-k,-h-l; twin fraction = 0.08) modeled. Analysis of the resultant maps showed poor density for large stretches of D1 with no extra density or residuals, and the R~free~ did not drop below 0.30. Therefore, we reprocessed the data in P1 (xia2, 3da mode) and resolved the structure with two copies of the complex in the asymmetric unit. Analysis of the P1 data set with Xtriage suggested twinning with only one of the three possible pseudomerohedral twinning operators (h,-k-l) significantly occupied (twin fraction = 0.46). Although the data merge well to 3.5 Å in both P2~1~ (R~pim~ = 0.077, R~merge~ = 0.105) and P1 (R~pim~ = 0.098, R~merge~ = 0.111), refinement carried out in the P1 data set in Phenix with the h,-k,-l operator modeled produced lower R factors than the P2~1~ refinement. After rebuilding in Coot ([@bib8]), the R~work~/R~free~ converged to 0.212/0.266 (compared to 0.248/0.300 for the same model in the P2~1~ data). Furthermore, the P1 maps showed clear features that differed between the two independent copies of the complex---in particular, the engineered disulfide (Cys346-Cys361) was clearer in one copy---and the pattern of thermal motion factors over the two molecules reproducibly refined to different distributions. Some stretches of D1 still had weak or no electron density associated with the model, although this varied between the two copies. However, refinement statistics worsen when these regions are removed, and molecular replacement of this domain placed it with *Z* score \> 15 in Phaser. Therefore, we decided to refine D1 in place and not rebuild in the density. The final refined P1 model gave good MolProbity statistics for the resolution (MolProbity score = 2.28, 99^th^ percentile). Running Xtriage with the final refined model in P1 gave R versus R statistics ([@bib27]) for the h,-k,-l operator of 0.132/0.373 (R~obs~/R~calc~), consistent with twinning with rotational pseudosymmetry.

Building a Model of the Early Prepore {#sec4.4}
-------------------------------------

A model for an early prepore was generated from the crystal lattice by bending a linear array containing 31 copies of the 1:1 ILY-CD59 complex into a circle. In brief, the linear array was placed onto the deposited pneumolysin prepore model (PDB [2BK2](pdb:2BK2){#intref0020}) by the superposition of D1--D3 with secondary structure mapping (lsqkab). Then, a 15.3° rotation was applied to make the linear array tangential to the circular prepore density (EMDB 1106). The linear array was then bent into the circular form by the application of a 0°, 0°, 11.6° rotation (polar angles) to a monomer. The CD59 N-linked glycan on Asn18 and the GPI anchor were modeled with the coordinates described in [@bib41], and kindly supplied by M. Wormald.

Preparation of Liposomes {#sec4.5}
------------------------

1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), and cholesterol (supplied in chloroform from Avanti Polar Lipids) were mixed in molar ratios of 3:3:2:2, respectively. Chloroform was evaporated with a stream of nitrogen gas, leaving a thin lipid film. Dried lipid was rehydrated with four freeze, thaw, and vortex cycles followed by extrusion through a 0.1 μm pore-size membrane (Avanti) for the formation of a homogeneous population of unilamellar liposomes, freshly prepared for each experiment. Fluorescently-labeled liposomes were generated by in the inclusion of 50 mM calcein (Sigma-Aldrich) in the rehydration buffer. This initial calcein concentration of 50 mM is sufficient to cause almost complete self-quenching of its fluorescence; if calcein is subsequently released from the liposomes, its concentration is reduced and an increase in fluorescence is observed. Unencapsulated dye was removed by passage through a G-50 Sephadex column (Sigma-Aldrich) run in a buffer containing 500 mM sucrose.

Lipid Flotation Assay {#sec4.6}
---------------------

Lipids were tracked by the inclusion of phosphatidylethanolamine with lissamine rhodamine B-labeled head groups (Avanti) in the lipid mixture described above at a final concentration of 2% (w/w) prior to the evaporation of chloroform. Extruded liposomes at a concentration of 1 mg/ml were incubated with either soluble or cytotopic CD59 at a final concentration of 18 μM. The liposome sample was adjusted to contain Ficoll at a final concentration of 20% (w/v) and was overlaid with 10% (w/v) Ficoll followed by buffer alone. After centrifugation at 100,000 × g at 20°C for 45 min, gradients were fractionated from the top. Fractions were analyzed for the presence of liposomes by the visualization of rhodamine and for the presence of CD59 by SDS-PAGE and Coomassie staining.

Fluorescence-Based Liposome Lysis Assay {#sec4.7}
---------------------------------------

Pore-formation assays were performed at 20°C in a Varian Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies) with excitation and emission wavelengths of 490 nm and 520 nm, respectively, and a slit width of 5 nm. The kinetics mode of the spectrophotometer was used with an average read time of 0.15 s, and measurements were made every minute. A peptide corresponding to the CD59-binding interface of ILY (residues 438--452) was synthesized with bridging N- and C-terminal cysteines (CEELGHDADGYETIRSC) (Severn Biotech). Cytotopic CD59 at a final concentration of 0.7 μM was incubated with 200 μl of fluorescently-labeled liposomes in the presence or absence of peptide, and the average background fluorescence intensity was measured for 10 min. Subsequently, ILY^WT^ at a final concentration of 0.7 μM was added to the reaction and the fluorescence was measured for 45 min. Liposomes were burst at the end of the experiment by the addition of 1 μl 0.2M C~12~E~8~ detergent (Sigma-Aldrich), and the maximum fluorescence was found by monitoring the sample for an additional 10 min. The fluorescence measurements for each reaction were normalized according to the background and detergent readings. Rates of calcein release (which corresponds to pore formation) were calculated by fitting the normalized fluorescence intensity data with a nonlinear fitting algorithm in OriginPro 8.6.

Cryo-Electron Microscopy {#sec4.8}
------------------------

We incubated 0.75 mg ml^−1^ liposomes with cytotopic CD59 and either ILY^WT^ or ILY^EPP^ in equimolar ratios so that the final protein concentration was 1 mg/ml. We applied 2.5 μl of the mixture to glow discharged holey carbon grids (QUANTIFOIL R 2/2) and vitrified in liquid ethane with an FEI Vitrobot. Images were acquired on a CM200 FEG electron microscope (FEI) operating at 200 kV. Images were recorded with a defocus range of −2.5 to −3.5 microns underfocus at a magnification of 38,000× and an electron dose of 20 e^−^/Å^2^ with a 4k × 4k TemCam-F415MP CCD camera (Tietz Video and Image Processing Systems).

Accession Numbers {#app1}
=================

The Protein Databank accession number for the ILY-CD59 complex reported in this paper is [4BIK](pdb:4BIK){#intref0030}.

Supplemental Information {#app3}
========================

Movie S1. Related to Figure 4A morph between the linear array observed in our crystal structure and the curved prepore intermediate. The structural transition between these two states was calculated with PyMOL. β1 and β4 strands of ILY are colored blue and red, respectively.Document S2. Article plus Supplemental Information

We thank T. Pape for technical support, R. Tweten for ILY constructs, and M. Wormald for CD59 coordinates containing modeled glycosylation and GPI anchor. We thank Diamond Light Source for synchrotron access and the staff at beamline I04. Cryo-EM images were collected at the Imperial College Electron Microscopy Centre. This work was supported by a Medical Research Council (MRC) grant (G0900888) to S.M.L and an Engineering and Physical Sciences Research Council Platform Grant (EP/G00465X) to the membrane biophysics group at Imperial College London. R.A.G.S. is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas's National Health Service Foundation Trust and the MRC Centre for Transplantation, King's College London. Work in S.M.L.'s lab is supported by the Oxford Martin School.

Supplemental Information includes two figures and one movie and can be found with this article online at [http://dx.doi.org/10.1016/j.celrep.2013.04.029](10.1016/j.celrep.2013.04.029){#intref0035}.

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

![Structure of the ILY-CD59 Complex\
(A) Two views of the complex related by 90°. The protein is shown in cartoon representation and colored by domain. ILY-D1, blue; ILY-D2, yellow; ILY-D3, green; ILY-D4, red; and CD59, gray.\
(B) A view of the crystal packing at the ILY-CD59 interface. ILY D1--D3 are shown as drawings and colored as in (A). ILY-D4 is colored red and shown as a drawing with a transparent surface. CD59 is colored gray and shown as a drawing with a transparent surface. A neighboring copy of the complex from the next unit cell is also shown with ILY rendered as a transparent drawing, and CD59 is shown in a light gray drawing with a transparent surface.\
(C--D) Zoom on the two ILY-CD59 interfaces in the crystal colored as in (B). Residues on CD59 and ILY that impact binding and function when mutated are shown in ball and stick and colored green and purple, respectively.\
Figures were rendered with PyMOL. See also [Figure S1](#figs1){ref-type="fig"}.](gr1){#fig1}

![ILY Pore Formation in a Model Membrane System\
(A) Cytotopic (top) and soluble CD59 (bottom) were incubated with liposomes and subjected to flotation through Ficoll (0%--20%). Gradients were fractionated from the top and aliquots run on Coomassie-stained SDS-PAGE gels. Lissamine rhodamine B-labeled liposomes banded at fractions 3 and 4. M, molecular weight markers. Arrows indicate the position of CD59 on the gel.\
(B) Calcein-containing liposomes were incubated with either cytotopic CD59 (red), ILY^WT^ (blue), or both proteins (black). The fluorescence due to calcein released from liposomes was measured as a function of time. The background was subtracted from the fluorescence intensity, and this was normalized according to the maximum intensity obtained after treatment with detergent. Error bars indicate the SD in normalized fluorescence intensity over three independent experiments. The average curve was fitted (green) with a nonlinear fitting algorithm (OriginPro 8.6), and a rate constant of 6.74 ± 0.13 min was determined.\
(C) Lytic activity of ILY in the presence of increasing concentrations of peptide expressed as a percentage relative to wild-type ILY. Each sample was tested in three different experiments. SEs are indicated.\
See also [Figure S2](#figs2){ref-type="fig"}.](gr2){#fig2}

![CD59 Coordinates ILY Monomers to Form the Pore\
(A) A cryo-EM image of ILY^WT^ pores formed on CD59-decorated liposomes. Black arrows indicate sites of bilayer disruption. The scale bar represents 100 nm.\
(B) A cryo-EM image field of the crystallized mutant form of ILY (ILY^EPP^) bound to CD59-decorated liposomes. ILY^EPP^ clusters on the surface of liposomes are highlighted within boxes. The scale bar represents 100 nm.](gr3){#fig3}

![Model for ILY Pore Formation\
(A) Soluble ILY (blue ribbons) targets human cell membranes by binding GPI-anchored CD59 (yellow ribbons). Modeling of CD59 glycosylation reveals that binding is not obstructed by sugars (orange sticks) and that the ILY undecapeptide loop (red) is positioned proximal to the plane of the membrane (gray slab). CD59 GPI anchor is shown in light green.\
(B) CD59 coordinates ILY monomers on the membrane through two distinct interfaces, nucleating an early prepore state.\
(C--D) Circularization of the linear array observed in our crystal structure maintains these two interfaces and suggests that CD59 binds on the periphery of the oligomeric ring.\
(C) Cross-section through the prepore oligomer.\
(D) Full oligomeric ring.\
Figures were rendered with PyMOL. See also [Movie S1](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Crystal Structure of the ILY-CD59 Complex, Related to [Figure 1](#fig1){ref-type="fig"}\
(A) Electron density (2Fo-Fc, blue mesh) overlaid with atomic models for ILY (green) and CD59 (red) at the complex interface. Black dashed lines show hydrogen bonds between β strands.\
(B) The two complexes in the asymmetric unit colored by atomic B factors (blue to red) and shown as Putty representation where the tube radius corresponds to the B factor.](figs1){#figs1}

![Normalized Fluorescence Intensity of Calcein-Containing Liposomes, Related to [Figure 2](#fig2){ref-type="fig"}\
Calcein-containing liposomes were incubated with cytotopic CD59, wild-type ILY and increasing concentrations of an ILY-derived peptide (residues 438-452) shown in (A--D). The fluorescence intensity of calcein released from liposomes was measured as a function of time and normalized to the background and detergent solubilized samples. A nonlinear fitting algorithm (OriginPro 8.6) was used to fit the data to an exponential decay and determine the time constants (t) for each concentration of peptide. Panels show representative normalized fluorescence curves for one of three independent experiments whose average was reported in [Figure 2](#fig2){ref-type="fig"}C.](figs2){#figs2}

###### 

Data Collection and Refinement Statistics

                               ILY^EPP^/CD59
  ---------------------------- ----------------------------------------------------------------------
  Space group                  P1
  Unit cell parameters (Å)     a = 27.4, b = 101.45, c = 112.88, α = 63.75°, β = 89.95°, γ = 90.02°
  Resolution (Å)               45.45-3.49 (3.62-3.49)
  No. unique reflections       13247 (1303)
  R~merge~                     0.111 (0.304)
  I/σ (I) mean                 7.3 (2.0)
  Completeness (%)             96.0 (96.9)
  Multiplicity                 2.0 (2.0)
  *R*~work~ /*R*~free~         0.212/0.266 (0.239/0.267)
  No. atoms                    
  Protein                      8387
  Ligand/ion                   0
  Water                        0
  Mean B factors (Å^2^)        103.00
  RMSDs                        
  Bond lengths (Å)             0.004
  Bond angles (°)              0.96
  Ramachandran plot analysis   
  Most favored regions (%)     95.0
  Disallowed regions (%)       0.2
  Molprobity score             2.28
  PDB code                     4BIK

Numbers in brackets refer to the highest resolution shell.
